Overview
Lorinna Lombardi is an Ophthalmologist in Tigard, Oregon. Dr. Lombardi is rated as a Distinguished provider by MediFind in the treatment of Glaucoma. Her top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Cataract, and Age-Related Macular Degeneration (ARMD). Dr. Lombardi is currently accepting new patients.
Her clinical research consists of co-authoring 10 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 5 articles and participated in 2 clinical trials in the study of Glaucoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- PPO
- EPO
- PPO
- EPO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
7 Clinical Trials
Claude Burgoyne is an Ophthalmologist in Portland, Oregon. Dr. Burgoyne is rated as a Distinguished provider by MediFind in the treatment of Glaucoma. His top areas of expertise are Ocular Hypertension (OHT), Glaucoma, Pigment-Dispersion Syndrome, Nearsightedness, and Vitrectomy. Dr. Burgoyne is currently accepting new patients.
Steven Mansberger is an Ophthalmologist in Portland, Oregon. Dr. Mansberger is rated as a Distinguished provider by MediFind in the treatment of Glaucoma. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Cataract Removal. Dr. Mansberger is currently accepting new patients.
Eye Care Physicians And Surgeons Inc
Shandiz Tehrani is an Ophthalmologist in Salem, Oregon. Dr. Tehrani is rated as a Distinguished provider by MediFind in the treatment of Glaucoma. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Cataract, Dry Eye Syndrome, and Trabeculectomy. Dr. Tehrani is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- GlaucomaDr. Lombardi isDistinguished. Learn about Glaucoma.
- Ocular Hypertension (OHT)Dr. Lombardi isDistinguished. Learn about Ocular Hypertension (OHT).
- Advanced
- Age-Related Macular Degeneration (ARMD)
- CataractDr. Lombardi isAdvanced. Learn about Cataract.
- Corneal Dystrophy and Perceptive Deafness
- Diabetic RetinopathyDr. Lombardi isAdvanced. Learn about Diabetic Retinopathy.
- Late-Onset Retinal DegenerationDr. Lombardi isAdvanced. Learn about Late-Onset Retinal Degeneration.
- Macular Corneal Dystrophy Type 1Dr. Lombardi isAdvanced. Learn about Macular Corneal Dystrophy Type 1.
- Experienced
- Adult-Onset Vitelliform Macular Dystrophy (AVMD)
- Allergic ConjunctivitisDr. Lombardi isExperienced. Learn about Allergic Conjunctivitis.
- AmblyopiaDr. Lombardi isExperienced. Learn about Amblyopia.
- Bell's PalsyDr. Lombardi isExperienced. Learn about Bell's Palsy.
- BlepharitisDr. Lombardi isExperienced. Learn about Blepharitis.
- Central Serous ChorioretinopathyDr. Lombardi isExperienced. Learn about Central Serous Chorioretinopathy.